Phase III Study of R-CVP Compared With Cyclophosphamide, Vincristine, and Prednisone Alone in Patients With Previously Untreated Advanced Follicular Lymphoma

Abstract

Analysis of all outcome measures, including OS, confirm the benefit of adding R to CVP in the front-line treatment of FL.